- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00468338
Correlation BIS Scores Mentally Retarded Patients
October 28, 2016 updated by: Rutgers, The State University of New Jersey
Correlation Between the Severity of Mental Retardation and BIS in Mentally Retarded Patients Undergoing Dental Rehabilitation
The BIS monitor is a tool which assists anesthesiologists in monitoring the depth of anesthesia or level of anesthesia.
The study doctors would like to see if it is useful tool for patients who are mentally challenged and require anesthesia.
Study Overview
Detailed Description
General endotracheal tube anesthesia (GETA) is administered for mentally retarded patients that need dental rehabilitation.
GETA is done, in all patients, with routine monitoring of electrocardiography, blood pressure recording, pulse oximetry and end-tidal capnography.
These measurements are also used indirectly to determine the depth of anesthesia and the anesthetic is titrated to prevent awareness during surgery and any subsequent recall (1).
In addition, a recently introduced functional electroencephalography (EEG)-based awareness monitor directly analyzes the brain wave pattern during anesthetic delivery and aids the anesthesiologist in maintaining the ideal depth of anesthesia.
The EEG based monitor serves to prevent awareness and recall due to light anesthesia or prolonged recovery following deep anesthesia (2).
This instrument, named the Bispectral Index Scale (BIS) monitor, is non-invasive and is approved by the Food & Drug Administration.
However, the BIS monitor is not being used routinely during the anesthetic management of mentally retarded patients due to a belief that such monitoring would be inaccurate in this cohort of patients (3).
This assumption lacks scientific validation.
Our trial will investigate the usefulness of BIS monitoring in mentally retarded patients and document any correlation between the severity of mental retardation and BIS scoring during various phases of anesthesia, such as awake status and sedation prior to anesthesia, induction and maintenance of anesthesia, and emergence and recovery from anesthesia.
The anesthetic protocol will be standardized and the anesthetic management will not deviate from routine practice.
The adjuvant therapies for infection prophylaxis and pain control will be administered in the usual fashion.
Study Type
Observational
Enrollment (Actual)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07103
- UMDNJ University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
mentally retarded persons ages 12 to 65 ubdergoing dental rehabilitation
Description
Inclusion Criteria:
- mentally retarded persons ages 12 to 65 undergoing dental rehabilitation
Exclusion Criteria:
- patients who are pregnant parents/and or legal guardians who do not wish to give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
BIS monitor used for all subjects
BIS monitor applied to all subjects
|
BIS monitor measures the depth of anesthesia and was used in the entire group
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rex Ponnudurai, MD, University of Medicine and Dentistry of New Jersey
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2006
Primary Completion (Actual)
May 1, 2008
Study Completion (Actual)
May 1, 2008
Study Registration Dates
First Submitted
April 30, 2007
First Submitted That Met QC Criteria
April 30, 2007
First Posted (Estimate)
May 2, 2007
Study Record Updates
Last Update Posted (Estimate)
November 1, 2016
Last Update Submitted That Met QC Criteria
October 28, 2016
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0120060266
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Retardation
-
Tokat Gaziosmanpasa UniversityCompletedProfound Mental Retardation
-
Hospices Civils de LyonUnknownX-linked Mental RetardationFrance
-
Ono Academic CollegeCompletedMental Retardation and Developmental Disabilities With Organic Condition
-
University of California, DavisUniversity of Alberta; St. Justine's HospitalRecruitingNeurobehavioral Manifestations | Genetic Diseases, X-Linked | Intellectual Disability | Fragile X Syndrome | Sex Chromosome Disorders | Fragile X Mental Retardation Syndrome | Trinucleotide Repeat Expansion | Fra(X) Syndrome | FXS | Mental Retardation, X LinkedUnited States, Canada
-
Instituto Politécnico de Castelo BrancoCompletedMental Retardation and Developmental Disabilities With No Organic Condition
-
Icahn School of Medicine at Mount SinaiRecruitingAutism Spectrum Disorder | DDX3X | Mental Retardation, X-linked 102United States
-
Central Hospital, Nancy, FranceCompletedGrowth Retardation
-
Tanzania Food and Drugs AuthorityUniversity Ghent; International Foundation for Science (IFS); The Nelson Mandela... and other collaboratorsCompleted
-
University of AlbertaSt. Justine's HospitalRecruitingNeurobehavioral Manifestations | Genetic Diseases, X-Linked | Mental Retardation, X-Linked | Intellectual Disability | Fragile X Syndrome | Sex Chromosome Disorders | Fragile X Mental Retardation Syndrome | Trinucleotide Repeat Expansion | Fra(X) Syndrome | FXSCanada
-
Neurogen Brain and Spine InstituteWithdrawn
Clinical Trials on BIS monitor
-
University of AberdeenNHS GrampianCompletedTraumatic Brain InjuryUnited Kingdom
-
Hospital Galdakao-UsansoloCompleted
-
Medical University of GrazRecruiting
-
Centro Hospitalar do Tâmega e SousaCompletedEEG Circadian Variation of ICU PatientsPortugal
-
Stryker InstrumentsCompletedAnesthesia, GeneralUnited States
-
Rabin Medical CenterUnknown
-
Hospital Galdakao-UsansoloCompleted
-
University of ManitobaCompletedInternal Carotid Artery StenosisCanada
-
University Health Network, TorontoCompleted
-
University Hospital OstravaCompletedCardiac Arrest | Cerebral Hypoxic InjuryCzechia